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Sometimes the application of a new technology prior to a complete understanding of that technology results in confusion, This seems to be the case regarding the clinical utility of assays for Beta-2-microglobulin (~2M), A veritable plethora of sometimes conflicting data has been generated by numerous investigators regarding the widely diverse clinical applications of~2M, Yet only a few clinicians are aware of its evistence and even fewer possess a good understanding of its potential usefulness, In order to critically evaluate the current literature and effectively utilize~2M, the clinician must understand its normal metabolism as well as other factors which may alter serum~2M concentrations or urinary excretion, 2M is a low molecular weight (11,800 Dalton) protein, found on the surface of nearly all cells, except erythrocytes. Structurally, it is similar to the constant domain of both heavy and light chain immunoglobulins. Although its specific function remains unknown, it appears to function as part of the H.LA complex.~2M is felt to be entirely metabolized by the kidney in a fashion similar to other low molecular weight proteins. Following glomerular filtration, 99.9% of the~2M filtered is reabsorbed and degraded by the proximal tubule resulting in minimal urinary excretion (1). Recent data suggest the possible existence of a peritubular mechanism for~2M catabolism (2, 3, 4). However, the relative importance of this mechanism to overall~2M clearance remains to be determined. Normally,~2M production rates are relatively constant resulting in a stable serum concentration (1) . A decrement in glomerular filtration rate will result in a proportional increase in serum~2M concentrations (2) . Thus, serum~2M concentrations may be useful as an indicator of glomerular filtration rate. However, overall~2M production may not always be constant. In fact,~2M production rate has been suggested to diminish with progressive age (5) . Conversely, increased production has been noted following stimulation of lymphocytesory diseases (1). Consequently, serum~2M concentrations may 215 change reflecting altered production despite a constant glomerular filtration rate.
Since 99.9% of the filtered~2M is reabsorbed by the proximal tubules, alterations in proximal tubular function, in the presence of a constant glomerular filtration and production rate, wilt result in increased~2M urinary excretion. Consequently, urinary~2M excretion may serve as a useful marker of tubular cell function (1) .
Recently, intense interest and excitement has been generated by reports that alterations of~2M in serum or urine may serve as a premonitory indicator of acute rejection episodes following renal transplantation (4, 7, 8) , and as a marker of aminoglycoside associated nephrotoxity (9) . However, critical examination of these reports demonstrates that the premonitory serum~2M alterations reported have not been seen in all acute rejection episodes studied, nor does renal functional impairment result in all subjects with increased urinary~2M excretion following aminoglycoside administration. Furthermore, there are no prospective data documenting the efficacy of treatment, or guidelines for modulation of drug dosage in adults based upon~2M levels alone, either following transplantation or the administration of potentially nephrotoxic drugs.
The conflicting data regarding increased serum~2M as a marker of some tumors and Crohn's (1) disease may result from the use of inappropriate control population. 2M serum levels are known to increase with age over the range of 17-76 years. This increase in serum concentration concomitant with presumed diminished production (5) probably results from a decreased glomerular filtration rate. Nevertheless, with advancing age serum~2M concentrations remain within established normal limits (5) . Although there is no significant difference in serum 2M levels between males and females at any given age range, values in males tend to be somewhat greater than those in females. Thus, a preponderance of a given age range or of one sex in a control population may influence statistics and amplify difference in a study population. Furthermore, other factors such as the status of the extracellular volume, urine pH, and the errors of measurements unique to this radioimmunoassay may also influence the determination of~2M in serum or urine (1). Thus, the clinician must take these factors into consideration when interpreting both the current literature and individual patient data.
In conclusion,~2M offerts great promise as a clinically useful indicator of glomerular filtration rate, proximal tubular function, and disease states associated with presumed increased production. However, the clinician must consider those renal and non-renal factors which may influence individual~2M determinations before making a clinical decision. The final definition of the overall clinical utility of~2M must await the results of prospective studies involving both the diagnostic accuracy and therapeutic interventions based solely on alterations of 2M.
